Molecular Response grants SuperGen rights to its tissue bank and molecular characterization technologies to discover and develop therapies for cancer

Molecular Response LLC

U.S. / Tools, Services, and Manufacturing

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

SuperGen Inc.

U.S. / Small-Cap Biopharma (<$1 billion)

$184.8m on 07/29/2011 [market cap]

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced